Novo Nordisk A/S NONOF Stock
Novo Nordisk A/S Price Chart
Novo Nordisk A/S NONOF Financial and Trading Overview
| Novo Nordisk A/S stock price | 46.01 USD |
| Previous Close | 49.8 USD |
| Open | 48 USD |
| Bid | 45 USD x 30000 |
| Ask | 47.68 USD x 10000 |
| Day's Range | 48 - 48.19 USD |
| 52 Week Range | 34 - 64.75 USD |
| Volume | 200 USD |
| Avg. Volume | 16.96K USD |
| Market Cap | 203.45B USD |
| Beta (5Y Monthly) | 0.36 |
| PE Ratio (TTM) | 10.954762 |
| EPS (TTM) | 4.2 USD |
| Forward Dividend & Yield | 1.81 (3.91%) |
| Ex-Dividend Date | March 27, 2026 |
| 1y Target Est | N/A |
NONOF Valuation Measures
| Enterprise Value | 329.14B USD |
| Trailing P/E | 10.954762 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | 3.09 |
| Price/Sales (ttm) | 0.62065715 |
| Price/Book (mrq) | 6.562731 |
| Enterprise Value/Revenue | 1.004 |
| Enterprise Value/EBITDA | 1.893 |
Trading Information
Novo Nordisk A/S Stock Price History
| Beta (5Y Monthly) | 0.36 |
| 52-Week Change | -6.71% |
| S&P500 52-Week Change | 18.32% |
| 52 Week High | 64.75 USD |
| 52 Week Low | 34 USD |
| 50-Day Moving Average | 46.61 USD |
| 200-Day Moving Average | 46.78 USD |
NONOF Share Statistics
| Avg. Volume (3 month) | 16.96K USD |
| Avg. Daily Volume (10-Days) | 9.02K USD |
| Shares Outstanding | 3.35B |
| Float | 3.18B |
| Short Ratio | N/A |
| % Held by Insiders | 5.28% |
| % Held by Institutions | 33.57% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 11.7 |
| Trailing Annual Dividend Yield | 23.49% |
| 5 Year Average Dividend Yield | 187.00% |
| Payout Ratio | 0.4269 |
| Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 37.20% |
| Operating Margin (ttm) | 61.57% |
| Gross Margin | 83.19% |
| EBITDA Margin | 53.04% |
Management Effectiveness
| Return on Assets (ttm) | 19.24% |
| Return on Equity (ttm) | 71.40% |
Income Statement
| Revenue (ttm) | 327.8B USD |
| Revenue Per Share (ttm) | 73.77 USD |
| Quarterly Revenue Growth (yoy) | 24.00% |
| Gross Profit (ttm) | 272.72B USD |
| EBITDA | 173.88B USD |
| Net Income Avi to Common (ttm) | 121.96B USD |
| Diluted EPS (ttm) | 4.2 |
| Quarterly Earnings Growth (yoy) | 67.20% |
Balance Sheet
| Total Cash (mrq) | 21.63B USD |
| Total Cash Per Share (mrq) | 4.87 USD |
| Total Debt (mrq) | 146.38B USD |
| Total Debt/Equity (mrq) | 72.09 USD |
| Current Ratio (mrq) | 0.788 |
| Book Value Per Share (mrq) | 7.010801 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 118.46B USD |
| Levered Free Cash Flow (ttm) | -12039249920 USD |
Profile of Novo Nordisk A/S
| Country | United States |
| State | N/A |
| City | Bagsvaerd |
| Address | Novo Alle 1 |
| ZIP | 2880 |
| Phone | 45 44 44 88 88 |
| Website | https://www.novonordisk.com |
| Industry | Drug Manufacturers - General |
| Sector(s) | Healthcare |
| Full Time Employees | 67900 |
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides NovoPen 6 and NovoPen Echo Plus, smart insulin pens; Dose Check, an insulin dose guidance application; growth hormone pens and injection needles; and Wegovy pill an oral glucagon-like peptide-1 (GLP-1) receptor agonist therapy for weight management. It operates in Europe, Canada, the United States, Japan, Korea, Oceania, Southeast Asia, Mainland China, Hong Kong and Taiwan, Latin America, the Middle East, and Africa. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Q&A For Novo Nordisk A/S Stock
What is a current NONOF stock price?
Novo Nordisk A/S NONOF stock price today per share is 46.01 USD.
How to purchase Novo Nordisk A/S stock?
You can buy NONOF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Novo Nordisk A/S?
The stock symbol or ticker of Novo Nordisk A/S is NONOF.
Which industry does the Novo Nordisk A/S company belong to?
The Novo Nordisk A/S industry is Drug Manufacturers - General.
How many shares does Novo Nordisk A/S have in circulation?
The max supply of Novo Nordisk A/S shares is 4.42B.
What is Novo Nordisk A/S Price to Earnings Ratio (PE Ratio)?
Novo Nordisk A/S PE Ratio is 10.95476200 now.
What was Novo Nordisk A/S earnings per share over the trailing 12 months (TTM)?
Novo Nordisk A/S EPS is 4.2 USD over the trailing 12 months.
Which sector does the Novo Nordisk A/S company belong to?
The Novo Nordisk A/S sector is Healthcare.
